Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium.

The expression of messenger RNA encoding neutral metalloproteinases and the tissue inhibitor of metalloproteinases (TIMP) in human arthritic synovium was evaluated in situ, using RNA probes. Interstitial collagenase and stromelysin were expressed by synovial lining cells in patients with active rheumatoid arthritis (RA). Proteinase messenger RNA was found both in cells expressing mononuclear phagocyte antigens and in cells that were negative for the antigens. TIMP was also expressed predominantly along the synovial lining layer. In highly inflammatory RA, TIMP expression appeared less intense than that of the proteases. In osteoarthritic synovium, TIMP was expressed at easily detectable levels, whereas the expression of collagenase and stromelysin was less prominent. The balance between expression of the metalloproteinases and of the metalloproteinase inhibitor in synovium appears to be altered during inflammation. These results are consistent with the notion that synovium plays different roles in the cartilage damage of RA and of osteoarthritis.

[1]  K. Tomita,et al.  Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[2]  H. Welgus,et al.  Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. , 1987, The Journal of clinical investigation.

[3]  R. Winchester,et al.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. , 1983, Journal of immunology.

[4]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[5]  E. Campbell,et al.  Monocyte procollagenase and tissue inhibitor of metalloproteinases. Identification, characterization, and regulation of secretion. , 1987, The Journal of biological chemistry.

[6]  H. Welgus,et al.  Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. , 1983, The Journal of biological chemistry.

[7]  Z. Werb,et al.  Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Krane,et al.  Human Collagenase: Identification and Characterization of an Enzyme from Rheumatoid Synovium in Culture , 1967, Science.

[9]  A. Eisen,et al.  Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. , 1986, The Journal of biological chemistry.

[10]  C. Dinarello,et al.  Isolation of an interleukin-1-like factor from human joint effusions. , 1983, Arthritis and rheumatism.

[11]  J. Pelletier,et al.  Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. , 1989, The Journal of clinical investigation.

[12]  S. Krane,et al.  Synovial collagenase: its presence in culture from joint disease of diverse etiology. , 1969, Arthritis and rheumatism.

[13]  S. Krane,et al.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Okada,et al.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. , 1986, The Journal of biological chemistry.

[15]  J. Niedel,et al.  Regulation of human synovial fibroblast collagenase messenger RNA by interleukin-1. , 1989, Arthritis and rheumatism.

[16]  D. Woolley,et al.  Collagenase at sites of cartilage erosion in the rheumatoid joint. , 1977, Arthritis and rheumatism.

[17]  A. Eisen,et al.  Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Thompson,et al.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Ruley,et al.  Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. , 1987, The Journal of biological chemistry.

[20]  B. Beutler,et al.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts , 1985, The Journal of experimental medicine.

[21]  A. Eisen,et al.  The collagen substrate specificity of human skin fibroblast collagenase. , 1981, The Journal of biological chemistry.

[22]  S. Krane,et al.  Rheumatoid arthritis: clinical features and pathogenetic mechanisms. , 1986, The Medical clinics of North America.

[23]  Z. Werb,et al.  Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. , 1985, The Journal of biological chemistry.

[24]  T. Broekelmann,et al.  A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. , 1986, The Journal of clinical investigation.

[25]  S. Krane,et al.  Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Ritz,et al.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin. , 1981, The Journal of clinical investigation.

[27]  B. Bresnihan,et al.  Analysis of the histologic variation of synovitis in rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[28]  P. Stephens,et al.  Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. , 1987, The Biochemical journal.

[29]  H. Nagase,et al.  Human recombinant interleukin‐1α‐mediated stimulation of procollagenase production and suppression of biosynthesis of tissue inhibitor of metalloproteinases in rabbit uterine cervical fibroblasts , 1988, FEBS letters.